表紙
市場調査レポート

痙性脳性麻痺:世界の治験レビュー

Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 309953
出版日 ページ情報 英文
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
痙性脳性麻痺:世界の治験レビュー Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014
出版日: 2014年07月31日 ページ情報: 英文
概要

当レポートでは、痙性脳性麻痺に関する臨床研究の最新動向について分析し、疾患治療法の概要や、治験における主要国、G7諸国およびE7(新興7カ国)における治験数および被験者採用の状況、フェーズ(相)段階別の進行状況、有望なスポンサー、各企業研究機関での研究の進行状況、有望な薬剤の比較といった情報をまとめてお届けします。

目次

イントロダクション

  • 痙性脳性麻痺
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋の主要5ヶ国における治験件数
    • 欧州の主要国における治験件数
    • 北米の主要国における治験件数
    • 中東およびアフリカの主要国における治験件数

G7諸国での治験件数:中枢神経系の治験件数に対する痙性脳性麻痺の治験件数比率

G7諸国での治験件数:フェーズ(相)別

G7諸国での治験件数:進捗状況別

E7諸国(新興7カ国)での治験件数:中枢神経系の治験件数に対する痙性脳性麻痺の治験件数比率

E7諸国(新興7カ国)での治験件数:進捗状況別

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ(相)別

進捗状況別の治験件数

エンドポイント達成状況別の治験件数

未達成の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

有望な薬剤

治験のプロファイル

  • 代表的な企業の治験概要
    • Medy-Tox Inc.
    • GlaxoSmithKline plc
    • 第一三共
  • 代表的な研究機関・病院の治験の概要
    • All India Institute of Medical Sciences
    • Gujarat Ayurved University
    • Azienda Ospedaliera Istituti Clinici Di Perfezionamento
    • Duke University Medical Center
    • Wright State University
    • ALYN Pediatric and Adolescent Rehabilitation Center
    • Erasmus MC
    • Chang Gung Memorial Foundation
    • National Center for Complementary and Alternative Medicine
    • Stanford University

5つの代表的な治験のプロファイル

付録

図表一覧

目次
Product Code: GlobalData

GlobalData's clinical trial report, "Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014" provides data on the Spastic Cerebral Palsy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Spastic Cerebral Palsy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Spastic Cerebral Palsy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Spastic Cerebral Palsy
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Spastic Cerebral Palsy
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Spastic Cerebral Palsy Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Medy-Tox Inc.
      • Clinical Trial Overview of Medy-Tox Inc.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
    • Clinical Trial Overview of Top Institutes / Government
      • All India Institute of Medical Sciences
      • Clinical Trial Overview of All India Institute of Medical Sciences
      • Gujarat Ayurved University
      • Clinical Trial Overview of Gujarat Ayurved University
      • Azienda Ospedaliera Istituti Clinici Di Perfezionamento
      • Clinical Trial Overview of Azienda Ospedaliera Istituti Clinici Di Perfezionamento
      • Duke University Medical Center
      • Clinical Trial Overview of Duke University Medical Center
      • Wright State University
      • Clinical Trial Overview of Wright State University
      • ALYN Pediatric and Adolescent Rehabilitation Center
      • Clinical Trial Overview of ALYN Pediatric and Adolescent Rehabilitation Center
      • Erasmus MC
      • Clinical Trial Overview of Erasmus MC
      • Chang Gung Memorial Foundation
      • Clinical Trial Overview of Chang Gung Memorial Foundation
      • National Center for Complementary and Alternative Medicine
      • Clinical Trial Overview of National Center for Complementary and Alternative Medicine
      • Stanford University
      • Clinical Trial Overview of Stanford University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Region, 2014*
  • Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Spastic Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Spastic Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Spastic Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Spastic Cerebral Palsy Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Spastic Cerebral Palsy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medy-Tox Inc., 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Gujarat Ayurved University, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Istituti Clinici Di Perfezionamento, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University Medical Center, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Wright State University, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by ALYN Pediatric and Adolescent Rehabilitation Center, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Chang Gung Memorial Foundation, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Complementary and Alternative Medicine, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014*

List of Figures

  • Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials, Europe, Top Countries (%), 2014*
  • Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Spastic Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Spastic Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Spastic Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Spastic Cerebral Palsy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top